Science ❯ Biology

Immunology

Immune Response Antibodies T Cells Immune System Cell Biology Vaccine Development Cancer Biology Autoimmunity Regulatory T Cells Cancer Immunotherapy

Severe Viral Pneumonia Tied to Higher Long-Term Lung Cancer Risk, Study in Cell Reports

Researchers report a 24% rise in lung cancer diagnoses over four years after hospitalization for severe COVID-19.

Early H3N2 Exposure Can Undercut Kids’ Antibodies to H1N1

UCLA Armored CAR T Cells Deliver Local VEGF Blockade, Improve Outcomes in Solid-Tumor Mouse Models

Stanford’s Broad-Acting Nasal Vaccine Shows Mouse Success as Human Trials Are Planned

Immune Signal IL-10 Tied to Faster Pain Recovery in Men, Study Finds

Stanford’s Nasal Vaccine Shows Broad, Months-Long Protection in Mice as Team Prepares Human Trials

Study Identifies Immune Off Switch Behind Why Pain Lasts Longer in Women

EU Grants Conditional Approval for ImmunityBio’s Anktiva in BCG‑Unresponsive Bladder Cancer

Lingering IFNγ, Not Fixed Epigenetics, Sustains Macrophage Memory, Study Finds

Pitt Study Identifies SerpinB2 as Key to Protective Fat Macrophages, Pointing to a New Diabetes Treatment Path

NEJM Study Identifies Viral Protein and Antibody Mutation Behind Rare Vaccine‑Linked Clots

UCSF Study Ties EBV Activity in Spinal Fluid to MS Through Surging CD8+ T Cells

Tumors Drive Neutrophils Into a CCL3hi State That Fuels Cancer, Study Finds

Broad Flu Antibody Nasal Spray Shows Safety and Strong Nasal Neutralization in Phase 1

Single Dose of Engineered HIV Vaccine Candidate Elicits Neutralizing Antibodies in Nonhuman Primates

Pregnant People With IBD Show Elevated Vaginal Inflammation, Study Finds

Southampton Team Engineers Four-Pronged Antibodies to Boost T‑Cell Activation in Preclinical Cancer Tests

Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion in Bet on Oral NLRP3 Drugs

Sanofi, Dren Bio Set Autoimmune Collaboration Worth Up to $1.7 Billion With $100 Million Upfront

Final Phase I Data Show Preventive TNBC Vaccine Is Safe and Induces Immune Responses in Most Participants